JAHA:全面!近40年来先天性心脏病的发病趋势分析

2021-07-19 MedSci原创 MedSci原创

单纯先天性心脏病患者的发病率和治疗率不断上升,而死亡率则不断下降,这表明人口在不断老化和增长。

先天性心脏病(CHD)是最常见的主要出生缺陷,占所有主要先天性缺陷的近三分之一。国际指南将CHD分为简单、中度和重度。由于过去几十年来诊断工具和治疗方法的改进,大多数患有CHD的儿童都能长大成人,而且据估计CHD在成人中的发病率已经超过了儿童。

以往的研究对单纯性 CHD 的预后趋势进行了调查,但都局限于单纯性 CHD 的亚组是基于超声心动图检查之前的旧队列,没有包括死亡风险的历年趋势,或者没有包括绝对风险,而是随时间变化的危险比,使得解释结果更加困难。

为了解决上述问题,来自丹麦哥本哈根大学血管病专家开展了一项全国性的研究,研究了39年来由所有简单CHD组成的队列中,发病率、诊断年龄、死亡风险和侵入性手术概率的时间趋势。结果发表在JAHA杂志上。

研究人员利用全国范围内的丹麦登记册确定了1977年至2015年期间被诊断为孤立性室间隔缺损、房间隔缺损、动脉导管未闭或肺动脉狭窄的人。报告了每10万人年的发病率及95%的CI,1年有创心脏手术概率和诊断时的年龄按诊断年龄分层(儿童≤18岁,成人>18岁),以及1年全因死亡率按诊断年龄组分层(5-30岁,30-60岁,60岁以上)。

最终,该研究确定了15900名患有单纯先天性心脏病的人(室间隔缺损,35.2%;房间隔缺损,35.0%;动脉导管未闭,25.2%;肺动脉狭窄,4.6%),其中75.7%为儿童。从1977年到1986年和2007年到2015年,成人(8.8到31.8)和儿童房间隔缺损(26.6到150.8)的发病率均有所上升。

而室间隔缺损(72.1 [95% CI, 60.3-83.9] 到 115.4 [95% CI, 109.1-121.6])、动脉导管未闭(49.2 [95% CI, 39. 8-58.5]到102.2[95%CI,86.7-117.6])和肺动脉狭窄(5.7[95%CI,3.0-8.3]至21.5[95%CI,17.2-25.7])的发病率上升只有儿童中只观察到,成年人的发病率保持不变。

1977年至2015年期间,丹麦18岁前被诊断的人的发病率和诊断时的年龄。

从1977-1986年到2007-2015年,观察到所有年龄组的1年死亡率都有所下降(>60岁,30.1%-9.6%;30-60岁,9.5%-1.0%;5-30岁,1.9%-0.0%)。同时,儿童的1年手术概率下降(13.8%-6.6%),但成人的1年手术概率上升(13.3%-29.6%)。

1977年至2015年期间,丹麦成人被诊断的人的发病率和诊断时的年龄。

研究人员指出,单纯先天性心脏病患者的发病率和治疗率不断上升,而死亡率则不断下降,这表明人口在不断老化和增长。需要对无症状的先天性心脏病采取更广泛的筛查方法,以启动及时的治疗和随访。

 

参考文献:

Time Trends in Simple Congenital Heart Disease Over 39 Years: A Danish Nationwide Study. https://doi.org/10.1161/JAHA.120.020375. Journal of the American Heart Association. ;0:e020375

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1667576, encodeId=86a3166e57676, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Mon Mar 07 02:57:25 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690186, encodeId=53a01690186f2, content=<a href='/topic/show?id=3f6c3e928af' target=_blank style='color:#2F92EE;'>#发病趋势#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37928, encryptionId=3f6c3e928af, topicName=发病趋势)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7e928986386, createdName=12498f6em16暂无昵称, createdTime=Fri Jan 28 03:57:25 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268583, encodeId=2e281268583e4, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Jul 21 03:57:25 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369554, encodeId=0d2d1369554e3, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Wed Jul 21 03:57:25 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000903, encodeId=f5b7100090357, content=不错,很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=184b5207042, createdName=147501a7m52暂无昵称, createdTime=Mon Jul 19 15:35:59 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1667576, encodeId=86a3166e57676, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Mon Mar 07 02:57:25 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690186, encodeId=53a01690186f2, content=<a href='/topic/show?id=3f6c3e928af' target=_blank style='color:#2F92EE;'>#发病趋势#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37928, encryptionId=3f6c3e928af, topicName=发病趋势)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7e928986386, createdName=12498f6em16暂无昵称, createdTime=Fri Jan 28 03:57:25 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268583, encodeId=2e281268583e4, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Jul 21 03:57:25 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369554, encodeId=0d2d1369554e3, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Wed Jul 21 03:57:25 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000903, encodeId=f5b7100090357, content=不错,很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=184b5207042, createdName=147501a7m52暂无昵称, createdTime=Mon Jul 19 15:35:59 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1667576, encodeId=86a3166e57676, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Mon Mar 07 02:57:25 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690186, encodeId=53a01690186f2, content=<a href='/topic/show?id=3f6c3e928af' target=_blank style='color:#2F92EE;'>#发病趋势#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37928, encryptionId=3f6c3e928af, topicName=发病趋势)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7e928986386, createdName=12498f6em16暂无昵称, createdTime=Fri Jan 28 03:57:25 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268583, encodeId=2e281268583e4, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Jul 21 03:57:25 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369554, encodeId=0d2d1369554e3, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Wed Jul 21 03:57:25 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000903, encodeId=f5b7100090357, content=不错,很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=184b5207042, createdName=147501a7m52暂无昵称, createdTime=Mon Jul 19 15:35:59 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2021-07-21 zhaohui6731
  4. [GetPortalCommentsPageByObjectIdResponse(id=1667576, encodeId=86a3166e57676, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Mon Mar 07 02:57:25 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690186, encodeId=53a01690186f2, content=<a href='/topic/show?id=3f6c3e928af' target=_blank style='color:#2F92EE;'>#发病趋势#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37928, encryptionId=3f6c3e928af, topicName=发病趋势)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7e928986386, createdName=12498f6em16暂无昵称, createdTime=Fri Jan 28 03:57:25 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268583, encodeId=2e281268583e4, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Jul 21 03:57:25 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369554, encodeId=0d2d1369554e3, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Wed Jul 21 03:57:25 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000903, encodeId=f5b7100090357, content=不错,很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=184b5207042, createdName=147501a7m52暂无昵称, createdTime=Mon Jul 19 15:35:59 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2021-07-21 huirong
  5. [GetPortalCommentsPageByObjectIdResponse(id=1667576, encodeId=86a3166e57676, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Mon Mar 07 02:57:25 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690186, encodeId=53a01690186f2, content=<a href='/topic/show?id=3f6c3e928af' target=_blank style='color:#2F92EE;'>#发病趋势#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37928, encryptionId=3f6c3e928af, topicName=发病趋势)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7e928986386, createdName=12498f6em16暂无昵称, createdTime=Fri Jan 28 03:57:25 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268583, encodeId=2e281268583e4, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Wed Jul 21 03:57:25 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369554, encodeId=0d2d1369554e3, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Wed Jul 21 03:57:25 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000903, encodeId=f5b7100090357, content=不错,很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=184b5207042, createdName=147501a7m52暂无昵称, createdTime=Mon Jul 19 15:35:59 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2021-07-19 147501a7m52暂无昵称

    不错,很好

    0

拓展阅读

JOP:先天性心脏病患儿的便血管理

大多数伴有便血的CHD患儿的BH发生率高于NEC,而单心室和手术患者的风险更高。

室间隔缺损的常见5种形态,速记!

室间隔缺损(VSD)是常见的先天性心脏病。约占新生儿先天性心脏病的20%~30%。室间隔缺损有较高的自然缩小和闭合率,有血流动力学意义的成人VSD的比例低于儿童。

Eur Heart J:先天性心脏病的早期混合心脏康复计划效果

这种早期的混合心脏康复方案改善了青少年CHD患者的HRQoL、体重指数、身体活动和疾病知识,为将QUALIREHAB方案推广到成年CHD和非先天性心脏病患者提供了可能性。

Nat Genet 哈佛医学院肖峰/张晓然/Sarah等解析非编码区点突变如何导致先天性心脏病

此论文全面解析了人类心肌细胞中增强子的活性和先天性心脏病中的非编码区点突变。

JOP:认知刺激的家庭环境在先天性心脏病儿童的认知表现和执行功能中的作用

支持父母提供认知刺激的家庭环境可以改善CHD儿童的EF。

JOP:先天性心脏病患儿围手术期脑损伤与神经发育的关系

研究表明,术前脑白质病变似乎是儿童早期粗大运动发育不良的最具预测性的MRI标志物。